Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
0tcA0d4zJZc5nkqA